Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2026-02-09 @ 2:35 PM
Study NCT ID:
NCT02136134
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2014-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2016-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-01
First Submit QC Date:
None
Study First Post Date:
2014-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-20
Results First Submit QC Date:
None
Results First Post Date:
2017-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-14
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED